| Virally suppressed group | Virological failure group | Low level viremia group | Any viremia group | P-value (α = 5 %) |
---|---|---|---|---|---|
Baseline CD4 cell count (cells/μl) | n = 45, Mean = 199 | n = 8, Mean = 183 |  |  | 0.74 |
n = 45, Mean = 199 |  | n = 12, Mean = 181 |  | 0.66 | |
n = 45, Mean = 199 |  |  | n = 20, Mean = 182 | 0.61 | |
 | n = 8, Mean = 183 | n = 12, Mean = 181 |  | 0.97 | |
CD4 cell count @ 6–12 months after treatment initiation (cells/μl) | n = 18, Mean = 387 | n = 8, Mean = 250 |  |  | 0.18 |
n = 18, Mean = 387 |  | n = 9, Mean = 438 |  | 0.58 | |
n = 18, Mean = 387 |  |  | n = 17, Mean = 350 | 0.64 | |
 | n = 8, Mean = 250 | n = 9, Mean = 438 |  | 0.07 | |
P-value (α = 5 %) | 0.0001 | 0.47 | 0.001 | 0.01 |  |